Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00230256 · ClinicalTrials.gov registry record
Treatment Outcomes and Quality of Life After IMRT Treatments of Head and Neck Cancers
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 61
- Enrollment target
NCT00230256: Completed study, sponsored by Stanford University.
NCT00230256 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 61 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00230256 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 61 participants
- Enrollment target
Study Summary
The purpose of the research study is to evaluate effectiveness and the quality of life, specifically the risk of dry mouth, after radiation treatment for head and neck cancers.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2003-04 |
| Est. Completion | 2008-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00230256
The ClinicalTrials.gov registry entry for NCT00230256 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00230256 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00230256 about?
NCT00230256 is a clinical study titled "Treatment Outcomes and Quality of Life After IMRT Treatments of Head and Neck Cancers". The purpose of the research study is to evaluate effectiveness and the quality of life, specifically the risk of dry mouth, after radiation treatment for head and neck cancers.
What is the current status of trial NCT00230256?
This trial is currently completed. The enrollment target is 61 participants. The study started on 2003-04. Estimated completion is 2008-12.
Who is sponsoring clinical trial NCT00230256?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.